Kostas Konstantopoulos

Kostas Konstantopoulos


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2003 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
KKKostas Konstantopoulos
Kostas Konstantopoulos
AKA Kanta
A Kanta
Constantinos DeltasConstantinos Deltas
Constantinos Deltas
VAV Atamian
V Atamian
DMD Mavrogianni
D Mavrogianni
HMH M Moutsopoulos
H M Moutsopoulos
Objective: To search for pyrin mutations associated with familial Mediterranean fever (FMF) in Greece. Patients and methods: 62 patients fulfilling the Tel Hashomer diagnostic criteria for definite (33) or probable (29) FMF diagnosis were studied. Eight point mutations of pyrin gene were tested by standard methods. Of the 62 patients tested, 48 were Greek, four were Jewish, seven were Armenian, and three were Arab. Results: 42 patients were found to be homozygotes for pyrin mutations; 11 patients were found to carry only one of the tested mutations; in nine patients no mutations were detected. Conclusion: Molecular detection of pyrin gene mutations seems useful in confirming suspected cases, and in detecting asymptomatic cases, of Mediterranean fever in Greece. It may also be used as a screening tool within affected families.

1 July 2002 in Dermatology
Verified
Journal Article
Closed access
PDF file
KKKostas Konstantopoulos
Kostas Konstantopoulos
APA. Papadogianni
A. Papadogianni
MDM. Dimopoulou
M. Dimopoulou
CKC. Kourelis
C. Kourelis
JMJ. Meletis
J. Meletis
A tyrosine kinase inhibitor (STI571, Gleevec) has recently been applied in the treatment of chronic myeloid leukemia. We present the first reported case of pityriasis rosea occurring as a reaction to Gleevec in a woman with blast crisis of this disorder. It is suggested that although coincidental, this exanthem may be due to this agent.

4 October 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
GMGiorgos Marinos
Giorgos Marinos
DLDimitrios Lamprinos
Dimitrios Lamprinos
PGPanagiotis Georgakopoulos
Panagiotis Georgakopoulos
GPGeorgios Patoulis
Georgios Patoulis
GVGeorgia Vogiatzi
Georgia Vogiatzi
George RachiotisGeorge Rachiotis
George Rachiotis
There are limited data on the prevalence and determinants of COVID-19 vaccination coverage among physicians. A cross-sectional, questionnaire-based, online study was conducted among the members of the Athens Medical Association (I.S.A.) over the period 25 February to 13 March 2021. All members of I.S.A. were invited to participate in the anonymous online survey. A structured, anonymous questionnaire was used. Overall, 1993 physicians participated in the survey. The reported vaccination coverage was 85.3%. The main reasons of no vaccination were pending vaccination appointment followed by safety concerns. Participants being informed about the COVID-19 vaccines by social media resulted in lower COVID-19 vaccination coverage than health workers being informed by other sources. Logistic regression analysis demonstrated that no fear over COVID-19 vaccination-related side effects, history of influenza vaccination for flu season 2020–2021, and the perception that the information on COVID-19 vaccination from the national public health authorities is reliable, were independent factors of reported COVID-19 vaccination coverage. Our results demonstrate a considerable improvement of the COVID-19 vaccination uptake among Greek physicians. The finding that participants reported high reliability of the information related to COVID-19 vaccination provided by the Greek public health authorities is an opportunity which should be broadly exploited by policymakers in order to combat vaccination hesitancy, and further improve COVID-19 vaccination uptake and coverage among physicians/HCWs, and the general population.

1 January 2001 in The Hematology Journal
Verified
Journal Article
Closed access
JMJohn Meletis
John Meletis
Evangelos TerposEvangelos Terpos
Evangelos Terpos
MSMichalis Samarkos
Michalis Samarkos
CMChristos Meletis
Christos Meletis
EAEffie Apostolidou
Effie Apostolidou
DLDimitris Loukopoulos
Dimitris Loukopoulos

1 January 2005 in International Journal of Hematology
Verified
Journal Article
Closed access
PDF file
KKKostas Konstantopoulos
Kostas Konstantopoulos
AKAlexandra Kanta
Alexandra Kanta
KLKonstantinos Lilakos
Konstantinos Lilakos
GPGeorge Papanikolaou
George Papanikolaou
IMIoannis Meletis
Ioannis Meletis
Familial Mediterranean fever (FMF) is an inherited disease characterized by recurrent inflammatory polyserositis. Although FMF is classically expected only in Middle East populations, it is becoming evident that the disease affects more groups than initially thought.The disease is associated with a number of mutations of the MEFV gene, which codes for a protein named pyrin. The role of E148Q pyrin gene mutation in the development of FMF remains inconclusive. Some authors believe it causes the disease, whereas others favor the concept of a noncausative role. To understand better the role of this mutation, gathering data from different populations may be of value.We studied 60 Greek cases fulfilling the criteria for FMF diagnosis, 30 cases being a definite FMF diagnosis and 30 a probable diagnosis. Twenty-one of the patients, carried mutation E148Q. One was a homozygote (E148Q/E148Q), and 20 carried mutation E148Q in combination with other mutations (compound heterozygotes). In 6 of the 60 cases studied, no mutations were found. Compared with the results for healthy controls, E148Q mutation is significantly frequent. Because different populations may exhibit different patterns of pyrin mutations, association of the E148Q mutation with FMF should be considered in connection with origin data.

1 March 2002 in Blood Cells, Molecules, and Diseases
Verified
Journal Article
Closed access
YRYannis Rombos
Yannis Rombos
RTRevekka Tzanetea
Revekka Tzanetea
VKVassiliki Kalotychou
Vassiliki Kalotychou
KKKostas Konstantopoulos
Kostas Konstantopoulos
SSSpyros Simitzis
Spyros Simitzis
PFPhaedon Fessas
Phaedon Fessas